BR9804504B1 - isoquinolina-3-carboxamidas substituÍdas, processo para a preparaÇço das mesmas e medicamento. - Google Patents

isoquinolina-3-carboxamidas substituÍdas, processo para a preparaÇço das mesmas e medicamento.

Info

Publication number
BR9804504B1
BR9804504B1 BRPI9804504-0A BR9804504A BR9804504B1 BR 9804504 B1 BR9804504 B1 BR 9804504B1 BR 9804504 A BR9804504 A BR 9804504A BR 9804504 B1 BR9804504 B1 BR 9804504B1
Authority
BR
Brazil
Prior art keywords
carboxamides
medicament
preparation
substituted isoquinoline
isoquinoline
Prior art date
Application number
BRPI9804504-0A
Other languages
English (en)
Other versions
BR9804504A (pt
Inventor
Klaus Dr Weidmann
Karl-Heinz Dr Baringhaus
Georg Dr Tschank
Ulrich Dr Werner
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed filed Critical
Publication of BR9804504A publication Critical patent/BR9804504A/pt
Publication of BR9804504B1 publication Critical patent/BR9804504B1/pt

Links

Classifications

    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07K—PEPTIDES
    • C07K5/00—Peptides containing up to four amino acids in a fully defined sequence; Derivatives thereof
    • C07K5/04—Peptides containing up to four amino acids in a fully defined sequence; Derivatives thereof containing only normal peptide links
    • C07K5/06—Dipeptides
    • C07K5/06139—Dipeptides with the first amino acid being heterocyclic
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00—Medicinal preparations containing organic active ingredients
    • A61K31/33—Heterocyclic compounds
    • A61K31/395—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins
    • A61K31/435—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins having six-membered rings with one nitrogen as the only ring hetero atom
    • A61K31/47—Quinolines; Isoquinolines
    • A61K31/472—Non-condensed isoquinolines, e.g. papaverine
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P1/00—Drugs for disorders of the alimentary tract or the digestive system
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P1/00—Drugs for disorders of the alimentary tract or the digestive system
    • A61P1/16—Drugs for disorders of the alimentary tract or the digestive system for liver or gallbladder disorders, e.g. hepatoprotective agents, cholagogues, litholytics
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P11/00—Drugs for disorders of the respiratory system
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P13/00—Drugs for disorders of the urinary system
    • A61P13/12—Drugs for disorders of the urinary system of the kidneys
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P15/00—Drugs for genital or sexual disorders; Contraceptives
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P17/00—Drugs for dermatological disorders
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P17/00—Drugs for dermatological disorders
    • A61P17/02—Drugs for dermatological disorders for treating wounds, ulcers, burns, scars, keloids, or the like
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P3/00—Drugs for disorders of the metabolism
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P39/00—General protective or antinoxious agents
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P43/00—Drugs for specific purposes, not provided for in groups A61P1/00-A61P41/00
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P9/00—Drugs for disorders of the cardiovascular system
    • A61P9/10—Drugs for disorders of the cardiovascular system for treating ischaemic or atherosclerotic diseases, e.g. antianginal drugs, coronary vasodilators, drugs for myocardial infarction, retinopathy, cerebrovascula insufficiency, renal arteriosclerosis
    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07D—HETEROCYCLIC COMPOUNDS
    • C07D217/00—Heterocyclic compounds containing isoquinoline or hydrogenated isoquinoline ring systems
    • C07D217/12—Heterocyclic compounds containing isoquinoline or hydrogenated isoquinoline ring systems with radicals, substituted by hetero atoms, attached to carbon atoms of the nitrogen-containing ring
    • C07D217/14—Heterocyclic compounds containing isoquinoline or hydrogenated isoquinoline ring systems with radicals, substituted by hetero atoms, attached to carbon atoms of the nitrogen-containing ring other than aralkyl radicals
    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07D—HETEROCYCLIC COMPOUNDS
    • C07D217/00—Heterocyclic compounds containing isoquinoline or hydrogenated isoquinoline ring systems
    • C07D217/22—Heterocyclic compounds containing isoquinoline or hydrogenated isoquinoline ring systems with hetero atoms or with carbon atoms having three bonds to hetero atoms with at the most one bond to halogen, e.g. ester or nitrile radicals, directly attached to carbon atoms of the nitrogen-containing ring
    • C07D217/24—Oxygen atoms
    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07D—HETEROCYCLIC COMPOUNDS
    • C07D217/00—Heterocyclic compounds containing isoquinoline or hydrogenated isoquinoline ring systems
    • C07D217/22—Heterocyclic compounds containing isoquinoline or hydrogenated isoquinoline ring systems with hetero atoms or with carbon atoms having three bonds to hetero atoms with at the most one bond to halogen, e.g. ester or nitrile radicals, directly attached to carbon atoms of the nitrogen-containing ring
    • C07D217/26—Carbon atoms having three bonds to hetero atoms with at the most one bond to halogen
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K38/00—Medicinal preparations containing peptides
BRPI9804504-0A 1997-10-20 1998-10-19 isoquinolina-3-carboxamidas substituÍdas, processo para a preparaÇço das mesmas e medicamento. BR9804504B1 (pt)

Applications Claiming Priority (1)

Application Number Priority Date Filing Date Title
DE19746287A DE19746287A1 (de) 1997-10-20 1997-10-20 Substituierte Isochinolin-2-Carbonsäureamide, ihre Herstellung und ihre Verwendung als Arzneimittel

Publications (2)

Publication Number Publication Date
BR9804504A BR9804504A (pt) 2001-05-22
BR9804504B1 true BR9804504B1 (pt) 2009-01-13

Family

ID=7846053

Family Applications (1)

Application Number Title Priority Date Filing Date
BRPI9804504-0A BR9804504B1 (pt) 1997-10-20 1998-10-19 isoquinolina-3-carboxamidas substituÍdas, processo para a preparaÇço das mesmas e medicamento.

Country Status (25)

Country Link
US (1) US6093730A (pt)
EP (2) EP1538160B1 (pt)
JP (2) JP3782591B2 (pt)
KR (1) KR100618922B1 (pt)
CN (1) CN1117079C (pt)
AR (1) AR013696A1 (pt)
AT (2) ATE432940T1 (pt)
AU (1) AU755714B2 (pt)
BR (1) BR9804504B1 (pt)
CA (2) CA2250664A1 (pt)
CZ (1) CZ337298A3 (pt)
DE (3) DE19746287A1 (pt)
DK (2) DK0911340T3 (pt)
ES (2) ES2245471T3 (pt)
HK (1) HK1019605A1 (pt)
HU (1) HUP9802422A3 (pt)
ID (1) ID21115A (pt)
IL (1) IL126638A0 (pt)
NO (1) NO312365B1 (pt)
NZ (1) NZ332363A (pt)
PL (1) PL192354B1 (pt)
PT (1) PT911340E (pt)
SG (1) SG87776A1 (pt)
TR (1) TR199802106A2 (pt)
ZA (1) ZA989505B (pt)

Families Citing this family (57)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
AU2001275014A1 (en) 2000-05-30 2001-12-11 Neurogen Corporation Imidazoloisoquinolines
US6762318B2 (en) * 2001-12-03 2004-07-13 Novo Nordisk A/S Glucagon antagonists
EP2324834B1 (en) * 2001-12-06 2019-05-08 Fibrogen, Inc. Methods of Increasing Endogenous Erythropoietin (EPO)
EP2295060B1 (en) 2001-12-06 2018-10-31 Fibrogen, Inc. Treatment or prevention of ischemic or hypoxic conditions
US8318703B2 (en) 2001-12-06 2012-11-27 Fibrogen, Inc. Methods for improving kidney function
US8124582B2 (en) * 2002-12-06 2012-02-28 Fibrogen, Inc. Treatment of diabetes
US7618940B2 (en) * 2002-12-06 2009-11-17 Fibrogen, Inc. Fat regulation
SI1644336T1 (sl) 2003-06-06 2011-06-30 Fibrogen Inc Heteroarilne spojine, ki vsebujejo duĺ ik in njihova uporaba pri zviĺ anju endogenega eritropoetina
US20060251638A1 (en) * 2003-06-06 2006-11-09 Volkmar Guenzler-Pukall Cytoprotection through the use of hif hydroxylase inhibitors
US8614204B2 (en) * 2003-06-06 2013-12-24 Fibrogen, Inc. Enhanced erythropoiesis and iron metabolism
EP1893186A2 (en) * 2005-06-06 2008-03-05 Fibrogen, Inc. Improved treatment for anemia using a hif-alpha stabilising agent
ATE470439T1 (de) 2005-06-15 2010-06-15 Fibrogen Inc Verwendung von hif 1alfa modulatoren zur behandlung von krebs
US7728130B2 (en) 2005-12-09 2010-06-01 Amgen Inc. Quinolone based compounds exhibiting prolyl hydroxylase inhibitory activity
WO2007090068A2 (en) 2006-01-27 2007-08-09 Fibrogen, Inc. Cyanoisoquinoline compounds that stabilize hypoxia inducible factor (hif)
WO2007101204A1 (en) * 2006-02-27 2007-09-07 Alcon Research, Ltd. Method of treating glaucoma
US7745461B1 (en) 2006-02-27 2010-06-29 Alcon Research, Ltd. Method of treating dry eye disorders
KR100949982B1 (ko) * 2006-03-30 2010-03-29 엘지전자 주식회사 비디오 신호를 디코딩/인코딩하기 위한 방법 및 장치
BRPI0710527B8 (pt) 2006-04-04 2021-05-25 Fibrogen Inc compostos de pirrolo- e tiazolo-piridina e composição farmacêutica que os compreende
CA2659682C (en) 2006-06-26 2010-12-21 The Procter & Gamble Company Prolyl hydroxylase inhibitors and methods of use
US7635715B2 (en) 2006-12-18 2009-12-22 Amgen Inc. Naphthalenone compounds exhibiting prolyl hydroxylase inhibitory activity, compositions, and uses thereof
US8048892B2 (en) 2006-12-18 2011-11-01 Amgen Inc. Azaquinolone based compounds exhibiting prolyl hydroxylase inhibitory activity, compositions, and uses thereof
WO2008130600A2 (en) 2007-04-18 2008-10-30 Amgen Inc. Quinolones and azaquinolones that inhibit prolyl hydroxylase
WO2008130508A1 (en) 2007-04-18 2008-10-30 Amgen Inc. Indanone derivatives that inhibit prolyl hydroxylase
WO2008137060A1 (en) 2007-05-04 2008-11-13 Amgen Inc. Thienopyridine and thiazolopyridine derivatives that inhibit prolyl hydroxylase activity
CA2685219C (en) 2007-05-04 2012-06-19 Amgen Inc. Diazaquinolones that inhibit prolyl hydroxylase activity
WO2009002533A1 (en) * 2007-06-27 2008-12-31 The Brigham And Women's Hospital, Inc. Inflammatory bowel disease therapies
CN101497584B (zh) * 2008-01-29 2010-12-22 首都医科大学 异喹啉-3-甲酰氨基酸苄酯及其制备和应用
DK2294066T3 (da) 2008-04-28 2014-09-08 Janssen Pharmaceutica Nv Benzoimidazoler som prolylhydroxylaseinhibitorer
CN105037323A (zh) 2008-11-14 2015-11-11 菲布罗根有限公司 作为hif羟化酶抑制剂的苯并噻喃衍生物
KR101706803B1 (ko) 2009-07-17 2017-02-14 니뽄 다바코 산교 가부시키가이샤 트리아졸로피리딘 화합물, 그리고 그 프롤릴 수산화효소 저해제 및 에리트로포이에틴 생성 유도제로서의 작용
NO2686520T3 (pt) 2011-06-06 2018-03-17
CN104024227B (zh) * 2011-07-22 2015-12-02 北京贝美拓新药研发有限公司 抑制脯氨酸羟化酶活性的化合物的晶型及其应用
IN2014DN03155A (pt) 2011-10-25 2015-05-22 Janssen Pharmaceutica Nv
WO2013134660A1 (en) 2012-03-09 2013-09-12 Fibrogen, Inc. 4 -hydroxy- isoquinoline compounds as hif hydroxylase inhibitors
MX350922B (es) 2012-07-16 2017-09-25 Fibrogen Inc Proceso para elaborar compuestos de isoquinolina.
US8883823B2 (en) 2012-07-16 2014-11-11 Fibrogen, Inc. Crystalline forms of a prolyl hydroxylase inhibitor
PT2872488T (pt) 2012-07-16 2018-11-22 Fibrogen Inc Formas cristalinas do ácido [(4-hidroxi-1-metil-7-fenoxi-isoquinolina-3-carbonil)amino]acético inibidor da prolil-hidroxilase
WO2014070859A1 (en) * 2012-10-30 2014-05-08 H. Lee Moffitt Cancer Center And Research Institute, Inc. Stat3 dimerization inhibitors
AU2014209319B2 (en) 2013-01-24 2018-04-19 Fibrogen, Inc. Crystalline forms of {[1-cyano-5-(4-chlorophenoxy)-4-hydroxy-isoquinoline-3-carbonyl]-amino}-acetic acid
WO2014197660A1 (en) 2013-06-06 2014-12-11 Fibrogen, Inc. Pharmaceutical formulations of a hif hydroxylase inhibitor
PT3007695T (pt) 2013-06-13 2024-03-07 Akebia Therapeutics Inc Composições e métodos para tratamento de anemia
PE20160945A1 (es) 2013-11-15 2016-09-26 Akebia Therapeutics Inc Formas solidas de acido {[5-(3-clorofenil)-3-hidroxipiridin-2-carbonil]amino}acetico, composiciones, y usos de las mismas
US10238675B2 (en) 2014-05-15 2019-03-26 Insmed Incorporated Methods for treating pulmonary non-tuberculous mycobacterial infections
CA2974691A1 (en) 2015-01-23 2016-07-28 Akebia Therapeutics, Inc. Solid forms of 2-(5-(3-fluorophenyl)-3-hydroxypicolinamido)acetic acid, compositions, and uses thereof
IL292262B2 (en) 2015-04-01 2024-02-01 Akebia Therapeutics Inc Formulation of an oral administration form of {[5-(3-chlorophenyl)-3-hydroxypyridine-2-carbonyl]amino}acetic acid
KR102473897B1 (ko) * 2015-05-28 2022-12-06 니뽄 다바코 산교 가부시키가이샤 당뇨병성 신증을 치료 또는 예방하는 방법
US20180200186A1 (en) * 2015-07-09 2018-07-19 Insmed Incorporated Compositions and methods for treating lung diseases and lung injury
AR108325A1 (es) 2016-04-27 2018-08-08 Samumed Llc Isoquinolin-3-il carboxamidas y preparación y uso de las mismas
AR108326A1 (es) 2016-04-27 2018-08-08 Samumed Llc Isoquinolin-3-il carboxamidas y preparación y uso de las mismas
KR20200112872A (ko) * 2018-01-09 2020-10-05 코넬 유니버시티 장기 섬유증의 예방 및 치료
WO2019191627A1 (en) 2018-03-30 2019-10-03 Insmed Incorporated Methods for continuous manufacture of liposomal drug products
AU2019265629A1 (en) 2018-05-09 2021-01-07 Akebia Therapeutics, Inc. Process for preparing 2-((5-(3-chlorophenyl)-3-hydroxypyridine-2-carbonyl)amino)acetic acid
WO2020028745A1 (en) * 2018-08-03 2020-02-06 Cornell University Methods for reducing abnormal scar formation
TW202120490A (zh) 2019-07-30 2021-06-01 德商拜耳動物保健有限公司 新穎異喹啉衍生物
US11524939B2 (en) 2019-11-13 2022-12-13 Akebia Therapeutics, Inc. Solid forms of {[5-(3-chlorophenyl)-3-hydroxypyridine-2-carbonyl]amino} acetic acid
CN112979541B (zh) * 2019-12-17 2022-11-11 浙江大学 一种基于n-(3-羟基吡啶-2-羰基)甘氨酸的抗肿瘤药物增敏剂及其应用
CN116120340B (zh) * 2021-11-15 2023-10-31 艾立康药业股份有限公司 一种吡啶并噁嗪类化合物及其制备方法、组合物和用途

Family Cites Families (9)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
DE4015255A1 (de) * 1990-05-12 1991-11-14 Hoechst Ag Oxalyl-aminosaeurederivate, verfahren zu ihrer herstellung und ihrer verwendung als arzneimittel zur inhibierung der prolyl-hydroxylase
CA2085954A1 (en) * 1991-12-24 1993-06-25 Klaus Weidmann Substituted pyridine n-oxides, processes for their preparation, and their use
TW352384B (en) * 1992-03-24 1999-02-11 Hoechst Ag Sulfonamido- or sulfonamidocarbonylpyridine-2-carboxamides, process for their preparation and their use as pharmaceuticals
DE4233124A1 (de) * 1992-10-02 1994-04-07 Hoechst Ag Acylsulfonamido- und Sulfonamidopyridin-2-carbonsäureester sowie ihre Pyridin-N-oxide, Verfahren zu ihrer Herstellung und ihre Verwendung als Arzneimittel
EP0650961B1 (de) * 1993-11-02 1997-03-05 Hoechst Aktiengesellschaft Substituierte heterocyclische Carbonsäureamide, ihre Herstellung und ihre Verwendung als Arzneimittel
DK0650960T3 (da) * 1993-11-02 1997-09-01 Hoechst Ag Substituerede heterocykliske carboxylsyreamid-estere, deres fremstilling og deres anvendelse som lægemidler.
CA2138929A1 (en) * 1993-12-30 1995-07-01 Klaus Weidmann Substituted heterocyclic carboxamides, their preparation and their use as pharmaceuticals
SE9400810D0 (sv) * 1994-03-10 1994-03-10 Pharmacia Ab New use of Quinoline-3-carboxamide compounds
IL135495A (en) * 1995-09-28 2002-12-01 Hoechst Ag Intermediate compounds for the preparation of quinoline-converted amines - 2 - carboxylic acid

Also Published As

Publication number Publication date
NO312365B1 (no) 2002-04-29
CN1117079C (zh) 2003-08-06
ES2245471T3 (es) 2006-01-01
NZ332363A (en) 2000-04-28
HUP9802422A2 (hu) 1999-08-30
ATE432940T1 (de) 2009-06-15
PT911340E (pt) 2005-09-30
CN1218802A (zh) 1999-06-09
TR199802106A3 (tr) 1999-05-21
NO984877D0 (no) 1998-10-19
IL126638A0 (en) 1999-08-17
CZ337298A3 (cs) 1999-05-12
HK1019605A1 (en) 2000-02-18
DE19746287A1 (de) 1999-04-22
SG87776A1 (en) 2002-04-16
EP1538160A1 (de) 2005-06-08
ID21115A (id) 1999-04-22
EP0911340B1 (de) 2005-07-06
EP0911340A3 (de) 1999-07-07
DE59814365D1 (de) 2009-07-16
DK1538160T3 (da) 2009-10-05
AU755714B2 (en) 2002-12-19
DE59812907D1 (de) 2005-08-11
JPH11302257A (ja) 1999-11-02
HUP9802422A3 (en) 2002-02-28
EP1538160B1 (de) 2009-06-03
BR9804504A (pt) 2001-05-22
KR19990037182A (ko) 1999-05-25
KR100618922B1 (ko) 2007-04-25
JP3782591B2 (ja) 2006-06-07
CA2251647C (en) 2011-08-30
AU8941398A (en) 1999-05-06
CA2250664A1 (en) 1999-04-20
EP0911340A2 (de) 1999-04-28
US6093730A (en) 2000-07-25
NO984877L (no) 1999-04-21
PL329274A1 (en) 1999-04-26
ES2328156T3 (es) 2009-11-10
JP2006056894A (ja) 2006-03-02
AR013696A1 (es) 2001-01-10
HU9802422D0 (en) 1998-12-28
ATE299148T1 (de) 2005-07-15
TR199802106A2 (xx) 1999-05-21
DK0911340T3 (da) 2005-11-07
JP4691419B2 (ja) 2011-06-01
PL192354B1 (pl) 2006-10-31
CA2251647A1 (en) 1999-04-20
ZA989505B (en) 1999-04-20

Similar Documents

Publication Publication Date Title
BR9804504B1 (pt) isoquinolina-3-carboxamidas substituÍdas, processo para a preparaÇço das mesmas e medicamento.
BR9712808B1 (pt) indol-3-glioxilamidas n-substituìdas, bem como aplicação, medicamento e processo para a preparação das mesmas.
BR9916192B1 (pt) formulações agroquìmicas, processo para a sua preparação e uso das mesmas.
BR9813857B1 (pt) Processo para a preparação de um desinfetante aquoso, e, desinfetante aquoso.
BR9802491B1 (pt) emulsço méltipla estavael, e, processo para formar a mesma.
BR9711318B1 (pt) processo para preparar intermediÁrios para florfenicol.
BR9800323B1 (pt) composição lìquida contendo gonadotropina, processo para preparar a mesma, cartucho, e, dispositivo de administração.
BR9804378B1 (pt) compostos, processo para sua produção e uso.
PT1124810E (pt) Derivados 2-amino-tiazole, processo para a sua preparacao e sua utilizacao como agentes anti-tumorais
BR9909730B1 (pt) dihidropirimidinas, bem como processo para a preparação e aplicação das mesmas.
BR9913455B1 (pt) Formulações de microcápsulas, bem como processo para preparação e emprego das mesmas
BR9914536B1 (pt) nço tecido perfurado, processo para sua produÇço, e referido uso.
BR9501980A (pt) Copolimeros,processo para sua preparação
BR9810552B1 (pt) composição depilatória, processo para preparar a mesma, e, uso da mesma.
BR9808730B1 (pt) processo de preparação de 1,1,1,3,3-pentaclorobutano.
BR0005766B1 (pt) processo para a preparação de massas de moldagem termoplásticas, massas de moldagem termoplásticas e uso das mesmas.
BR9914484B1 (pt) Formulações de microcápsulas, bem como processo para a preparação e aplicação das mesmas
BR0013913B1 (pt) compósito lubrificante e processo para a sua preparação.
BR0015675B1 (pt) composição de gel aerado, estável em armazenagem, e, processo para a produção da mesma.
BR9805538B1 (pt) processo para a preparação de ferro-succinilcaseìna.
PT1053224E (pt) Bifenilsulfonilcianamida, processo para a sua preparacao e sua utilizacao como medicamento
PT1157020E (pt) 1,2,3,4,5,6-hexa-hidro-2,6-metano-3-benzazocin-10-ois substituidos processo para a sua preparacao e sua utilizacao como medicamentos
BR9800928B1 (pt) material cosmético, e, processo para preparar o mesmo.
BR9814266B1 (pt) processo para a preparação de oxazafosforin-2-aminas.
BR9713912B1 (pt) composição inseticida e miticida, e, processo para a preparação da mesma.

Legal Events

Date Code Title Description
TC Change of name
B25A Requested transfer of rights approved

Free format text: AWEGA PATENTMANAGEMENT GMBH (DE)

B07A Application suspended after technical examination (opinion) [chapter 7.1 patent gazette]
B09A Decision: intention to grant [chapter 9.1 patent gazette]
B25A Requested transfer of rights approved

Owner name: FIBROGEN, INC. (US)

Free format text: TRANSFERIDO DE: AWEGA PATENTMANAGEMENT GMBH

B16A Patent or certificate of addition of invention granted [chapter 16.1 patent gazette]

Free format text: PRAZO DE VALIDADE: 10 (DEZ) ANOS CONTADOS A PARTIR DE 13/01/2009, OBSERVADAS AS CONDICOES LEGAIS.

B21A Patent or certificate of addition expired [chapter 21.1 patent gazette]

Free format text: PATENTE EXTINTA EM 13.01.2019